Bogart Wealth’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.48K Buy
13
+7
+117% +$825 ﹤0.01% 1563
2026
Q2
$640 Sell
6
-7
-54% -$848 ﹤0.01% 1719
2026
Q1
$2.13K Buy
13
+6
+86% +$922 ﹤0.01% 1264
2025
Q4
$1.22K Buy
7
+3
+75% +$547 ﹤0.01% 1277
2025
Q3
$576 Buy
+4
New +$490 ﹤0.01% 1376
2025
Q2
– Sell
-6
Closed -$458 – 1497
2025
Q1
$458 Buy
+6
New +$459 ﹤0.01% 1308

Other funds holding INSM

Bogart Wealth's INSM Position: Q3 2026 in Review

Bogart Wealth increased its Insmed (INSM) stake by 117% in Q3 2026, buying an estimated $825 and bringing the position to 13 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

Bogart Wealth first reported a position in INSM in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.13K in Q1 2026. 547 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Bogart Wealth held 13 shares of Insmed worth $1.48K as of Q3 2026.
  • Bogart Wealth bought 7 Insmed shares in Q3 2026, an estimated $825.
  • Insmed made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1563 holding.
  • Bogart Wealth first reported a position in Insmed in Q1 2025 and has held it in 6 quarters since.
  • Bogart Wealth's Insmed position peaked at $2.13K in Q1 2026.
  • 547 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.